Delivery Order SPE2DB20D2104-SPE2DB25FMNLG

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,850.93, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,649.65, is a Delivery Order for the supply of OTEZLA 30 MG TABLET 60S. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,748.01, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and an ultimate completion date of July 5, 2024. This award is associated with a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,816.35, is for the delivery of OTEZLA 30 mg tablets. The contract is a Firm Fixed Price, Delivery Order type with a period of performance through July 9, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,287.85, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 28, 2023 and is a Firm Fixed Price agreement. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,805.89, is a delivery order contract type with a firm fixed price pricing structure. The award is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a performance period through December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,821.76 Firm Fixed Price Delivery Order contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a performance period ending on February 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $13,500.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a performance period ending on January 21, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,489.40, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2025. The contract was awarded on March 31, 2025 and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,724.50 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNLG
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,853.24, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/14/25, 10:47 AM